Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC
Clinical trial NCT03673137 · COMPLETED
Trial details
- NCT number
- NCT03673137
- Sponsor
- Fuda Cancer Hospital, Guangzhou
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2021-06-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.